baber/WOPTO huggingface dataset:
Patent CA-3134410-A1 (CA)
Inventor: WANG BIAO
IPC: H04N19/11
Filed: 2020-03-23
Abstract: Devices and methods for Intra prediction are provided. The method relates to the field of picture processing and includes: obtaining a value of a first indication information of a current block; and obtaining a value of a reference index line of the current block. When the value of the first indication information indicates an intra prediction mode of the current block is comprised in a set of most probable modes, and when the value of the reference index line indicates the closest neighboring reference line to the current block is used, the method further includes obtaining a value of a second indication information indicating whether the intra prediction mode of the current block is Planar mode or not. The method can improve the efficiency to determine the intra prediction mode of the current block.
Patent CA-3137386-A1 (CA)
Inventor: ZHU LEI
IPC: H04R9/06
Filed: 2020-04-03
Abstract: Dans le dispositif terminal décrit dans la présente divulgation, un boîtier de dispositif comprend un espace d'installation et une première cavité intérieure qui sont isolés l'un de l'autre. Un haut-parleur est installé dans l'espace d'installation. Le haut-parleur comprend un boîtier de haut-parleur ayant une rosace et une deuxième cavité intérieure, et un élément vibrant, un amplificateur de signaux et un corps de haut-parleur disposés dans la deuxième cavité intérieure. Les première et deuxième cavités intérieures sont isolées l'une de l'autre. Une carte de circuit imprimé est installée dans la première cavité intérieure. La carte de circuit imprimé est pourvue d'un module de traitement de signaux sonores et d'un dispositif de génération d'ondes sonores de vibration. Le dispositif de génération d'ondes sonores de vibration est connecté au module de traitement de signaux sonores. Le dispositif de génération d'ondes sonores de vibration convertit un signal sonore envoyé par le module de traitement de signaux sonores en un signal de vibration. L'élément vibrant vibre sous l'action du signal de vibration et génère un signal électrique. L'amplificateur de signaux est connecté à l'élément vibrant et amplifie le signal électrique; et le corps de haut-parleur est connecté à l'amplificateur de signaux et produit un son à travers la rosace en fonction du signal électrique amplifié.
Patent CA-3140032-A1 (CA)
Inventor: ALBACH ROLF
IPC: C08G18/48
Filed: 2020-07-06
Abstract: The invention relates to a polyol formulation for producing flameproof polyurethane/polyisocyanate rigid foams (referred to individually or jointly in the following as "PUR/PIR rigid foams"), containing a polyester polyol having an OH number = 250 mg KOH/g, a functionality of 1.5 to 2.5 and a free glycol content with Mn < 150 g/mol of < 6 wt.%, a polyethylene glycol with an average molecular weight of < 700 g/mol and an average functionality of < 2.5 and specific polyethyleneglycol alkylphenyl ethers, and to methods for producing PUR/PIR rigid foams using said polyol formulation and to the PUR/PIR rigid foams obtained thereby.
Patent CA-3140123-A1 (CA)
Inventor: HASSIG CHRISTIAN ANDREW
IPC: A61K31/5377
Filed: 2020-05-13
Abstract: La présente invention concerne des méthodes d'utilisation d'un inhibiteur de kinase 1 de point de contrôle (Chkl) pour le traitement du cancer chez un sujet présentant au moins une charge de mutation de tumeur intermédiaire (TMB), ou une anomalie génétique d'un ou de plusieurs gènes particuliers associés à un stress de réplication. L'invention concerne par conséquent des méthodes de traitement du cancer chez un sujet présentant au moins une charge de mutation de tumeur intermédiaire (TMB-I). L'invention concerne également des méthodes de traitement du cancer chez un sujet présentant une anomalie génétique d'un ou de plusieurs gènes particuliers choisis parmi des gènes de régulation de cycle cellulaire, des gènes de stress de réplication, des mutations de gènes induisant une transformation en oncogènes et des gènes de réseau de réponse à un endommagement de l'ADN et de réparation de ce dernier. L'invention concerne également des méthodes de sélection de sujets pour une thérapie d'inhibition de Chkl. Les méthodes peuvent consister à administrer au sujet une quantité efficace d'un composé SRA737, dans certains cas en combinaison avec de la gemcitabine à faible dose.
Patent CA-3143200-A1 (CA)
Title: Sterile barrier systems and methods for robotic surgery systems
Inventor: GENOVA PERRY A
IPC: A61B34/37
Filed: 2020-06-16
Abstract: A sterile barrier system for a robotic surgery apparatus can include a drape coupler. The drape coupler can include an external surface configured to face a first surface of a first portion of the robotic surgery apparatus. The drape coupler can include at least one drape coupler fastener positioned at least partially on the external surface and configured to removably attach the drape coupler to the first surface. The drape coupler can be configured to at least partially cover the first surface. The system can include a drape made of a flexible material and coupled to the drape coupler, the drape configured to wrap around a second surface of the first portion of the robotic surgery apparatus, the second surface different from the first surface. The drape coupler and the drape can be sterile.
Patent CA-3143436-A1 (CA)
Title: Conjugates of .pi.-electron-pair-donating heteroaromatic nitrogen-comprising compounds
Inventor: BISEK NICOLA
IPC: C07D231/06
Filed: 2020-06-19
Abstract: The present invention relates to conjugates of p-electron-pair-donating heteroaromatic nitrogen-comprising drugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said conjugates and the use of said conjugates as medicaments.
Patent CA-3145621-A1 (CA)
Inventor: KLEPPE MARY
IPC: A61K39/00
Filed: 2020-08-14
Abstract: La présente invention concerne des formulations pharmaceutiques à concentration élevée et à faible viscosité qui comprennent un anticorps anti-C5 ou un fragment de liaison à l'antigène associé et de l'arginine. De telles formulations peuvent être fournies en association avec une molécule d'ARNi telle que le cemdisiran. L'invention concerne également des méthodes de traitement de maladies associées à C5 telles que l'hémoglobinurie paroxystique nocturne (HPN) et le syndrome hémolytique et urémique atypique (SHU atypique).
Patent CA-3146211-A1 (CA)
Inventor: KANG KU SUK
IPC: A61P3/00
Filed: 2020-07-20
Abstract: The present invention relates to a method for synthesizing a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative. When the method is used, a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative can be effectively synthesized.
Patent CA-3146799-A1 (CA)
Inventor: MERUELO DANIEL
IPC: C12N15/13
Filed: 2020-07-08
Abstract: The present disclosure provides compositions and methods for the treatment of cancer. More specifically, the present disclosure provides compositions and methods utilizing a combination of an oncolytic viruses, such as Sindbis virus, and antibodies directed against a co-stimulatory molecule or to an immune system agonist molecule, such as anti-OX40 antibodies and anti-4-1BB antibodies.
Patent CA-3146846-A1 (CA)
Inventor: THOR KARL
IPC: A61K36/81
Filed: 2019-07-18
Abstract: Methods, pharmaceutical formulations, and kits are provided for using capsaicin to effectuate voluntary defecation in mammals who cannot defecate without external invasion of the bowel or those who defecate involuntarily (i.e., those having fecal incontinence). The pharmaceutical formulations and kits can also be useful for inducing defecation in mammals that do not have defecation dysfunction such as, for example, in a person who is unconscious and may defecate unconsciously or in a pet at a convenient location at a specific time. The methods and compositions provide patients with defecation dysfunction control over when and where they defecate.
Patent CA-3149676-A1 (CA)
Title: Compositions de soin buccodentaire presentant une production de mousse accrue et leurs methodes
Inventor: DAS ARADHANA
IPC: A61K8/46
Filed: 2020-08-26
Abstract: La présente invention concerne des compositions de soin buccodentaire présentant des propriétés moussantes améliorées qui comprennent un acide aminé basique, un abrasif et un tensioactif taurate, ainsi que des méthodes d'utilisation de ces compositions. Facultativement, les compositions de soin buccodentaire comprennent en outre un polyglucoside d'alkyle.
Patent CA-3152816-A1 (CA)
Inventor: LANDBO TROND
IPC: B63B21/26
Filed: 2020-08-28
Abstract: Weak soil anchor device (1 ) for anchoring a number of structures, as well as method for arranging an anchoring in weak soils. Seen in a vertical operating position, the weak soil anchor device (1 ) comprises: an elongate inner continuous open box structure (2) with a triangular cross-section comprising a first wall surface (3), second wall surface (4) and third wall surface (5), an outer continuous open box structure (10) with a smaller vertical extent than the inner box structure (2) and having a triangular cross-section consisting of a first outer wall surface (11 ), second outer wall surface (12) and third outer wall surface (13), the vertical center area (14) of the first, second and third outer wall surfaces is connected to the inner elongate continuous open box structure (2) in a lower area of respectively an outer edge area between the first and second wall surface (3, 4), second and third wall surface (4, 5) and the third and first wall surfaces (5, 3), and anchor brackets (20) are arranged in a lower outer area of the weak soil anchor device (1 ), where the weak soil anchor device comprising the inner and outer box structure (2, 10) is lowered down into the weak soils to a desired depth.
Patent CA-3152858-A1 (CA)
Inventor: Wang Chuandui
IPC: G06Q10/06
Filed: 2020-06-24
Abstract: A link-based risk user identification method and device, belonging to the field of computer technology. The method comprises: acquiring at least one piece of behavior data generated by a user on the current page of a client (S1); analyzing the at least one piece of behavior data to obtain risk information about the current page (S2); determining whether the current link node corresponding to the current page is a first node of a link, wherein link nodes corresponding to at least one page are used to form a link according to a time sequence (S3); if so, recording the risk information about the current page as the risk information about the current link node (S4); if not, calculating risk information about the current link node according to the risk information about the current page and risk information about a previous link node of the current link node on the link (S5); and identifying, according to the risk information about all the link nodes on the link containing the current link node, whether the user is a risk user (S6). The method is able to accurately and reliably identify a risk user.
Patent CA-3154825-A1 (CA)
Inventor: ARCHIBALD ROGER
IPC: E21B43/1185
Filed: 2020-10-16
Abstract: A convertible and addressable switch assembly (632) includes an interface (I/O) configured to connect (800) to a controller (206) along a telemetry system (205); and a processor (PA) connected to the interface (I/O). The processor is configured to receive (802) a command from the controller (206), along the telemetry system (205), to change a first value of a mode status variable to a desired second value, wherein the first value is associated with a first operating mode of the switch assembly (632) and the second value is associated with a second operating mode, which is different from the first operating mode; change (804) the first value to the second value within the switch assembly (632); and store (806) in a non-volatile memory (238), at the switch assembly (632), the second value of the mode status variable.
Patent CA-3155512-A1 (CA)
Inventor: KASINATHAN POOTHAPPILLAI
IPC: C12Q1/6809
Filed: 2013-10-18
Abstract: Genetic tests, such as whole genome analysis (WGA), have been employed to identify genetically superior embryos. The disclosed methods extend in vitro culture time of embryos while awaiting results of genetic tests being performed on a portion of the same embryos. The disclosed methods also help expand the number of cells in each embryo before implantation in the recipient.
Patent CA-3156730-A1 (CA)
Inventor: BURGGRAAFF MAARTEN CORNELIS
IPC: B08B9/027
Filed: 2020-11-16
Abstract: A modular decoking assembly with a transportable container and multiple prefabricated modules that can be installed within the transportable container, and methods of forming a decoking unit with a plurality of prefabricated modules within a container.
Patent CA-3157658-A1 (CA)
Title: Compose 2,6-dioxo-3,6-dihydropyrimidine, bactericide agricole et horticole, nematicide et agent antifongique medical et veterinaire
Inventor: TERANISHI Takaaki
IPC: A01N43/60
Filed: 2020-10-26
Abstract: Le problème à résoudre par la présente invention concerne la fourniture : d'un composé 2,6-dioxo-3,6-dihydropyrimidine présentant une excellente activité bactéricide et une excellente innocuité, et pouvant être avantageusement synthétisé industriellement ; et un bactéricide agricole et horticole, un nématicide et un agent antifongique médical et vétérinaire le contenant en tant que principe actif. La présente invention concerne un composé représenté par la formule (II) ou un sel de celui-ci. Dans la formule (II), chaque Y1 est un atome d'oxygène ou un atome de soufre ; Y2 est un atome d'oxygène ou un atome de soufre ; Z est un groupe représenté par C-X1 ou un atome d'azote ; X1 représente un atome d'hydrogène, un groupe halogéno ou similaire ; X2 est un groupe représenté par R1O-N=CR6- ou similaire ; R1 représente un groupe alkyle en C1-6 linéaire substitué ou non substitué ou similaire ; R6 représente un groupe alkyle en C1-6 linéaire substitué ou non substitué ou similaire ; X3 représente un groupe alkyle en C1-6 linéaire substitué ou non substitué, un groupe alcényle en C2-6 linéaire substitué ou non substitué ou similaire ; A est un groupe alkylène en C1-6 substitué ou non substitué, un groupe alcénylène en C2-6 substitué ou non substitué, ou similaire ; et Q est un groupe aryle en C6-10 substitué ou non substitué ou un groupe hétéroaryle cyclique à 5-10 chaînons substitué ou non substitué.
Patent CA-3157734-A1 (CA)
Inventor: HENDRICKSON PETER CARL
IPC: G06N10/00
Filed: 2020-11-05
Abstract: A quantum computing (QC) system that includes a plurality of qubits arranged substantially in a plurality of substantially planar regions that are substantially parallel to one another, at least some of the substantially planar regions including two or more qubits and one or more qubits of each substantially planar region configured to interact with one or more qubits of at least one other substantially planar region.
Patent CA-3158935-A1 (CA)
Title: Hepatitis b virus core protein and surface antigen protein and vaccine comprising the same
Inventor: WEINER DAVID B
IPC: C12N15/86
Filed: 2013-09-19
Abstract: Provided herein are nucleic acid sequences encoding hepatitis B virus (HBV) core proteins, surface antigen proteins, fragments and combinations thereof as well as genetic constructs/vectors and vaccines that express said protein sequences. These vaccines are able to induce an immune response peripherally and in the liver by recruiting both cellular and humoral agents. Also provided are methods for prophylactically and/or therapeutically immunizing individuals against HBV. The combination vaccine can also be used for particular design vaccines for particular levels of immune responses to HBV challenge. Date Recue/Date Received 2022-05-16
Patent CA-3159807-A1 (CA)
Title: A jointless concrete composite pavement
Inventor: CEPURITIS ROLANDS
IPC: E01C7/14
Filed: 2020-09-14
Abstract: The present invention provides a pavement system comprising (i) a gap-graded concrete first layer 1; (ii) a flexural-hardening fiber reinforced mortar second layer 2, wherein the gap-graded concrete comprises cement, water and coarse aggregate with particles size from 4 to 45 mm; the flexural-hardening fiber reinforced mortar comprises cement; water, fine aggregate with a maximum particle size of not greater than 8 mm; fiber reinforcement comprising of synthetic and/or metal fibers 3 having diameter of 10 to 500 microns and length of 3 to 35 mm; wherein the total thickness of the composite pavement is selected depending on the required maximum service point load; wherein the ratio of the thickness of flexural-hardening fiber reinforced mortar second layer 2 to the total thickness of the composite pavement is within the range of 1:5 to 2:5.
Patent CA-3160923-A1 (CA)
Title: Techniques for sub-micron radial alignment of electric motor components and air flow management to extend motor lifespan
Inventor: AINI REZA
IPC: H02P25/03
Filed: 2020-12-04
Abstract: The present disclosure is generally directed to techniques for radial alignment of motor components relative to each other to achieve a motor with a rotor bore having sub-micron end-to-end deviation. In an embodiment, a rotor bore alignment tool is disclosed herein that can be inserted between motor components, and more particularly, apertures/through holes defined by each of the motor components such as housing sections and a stator assembly. The rotor bore alignment tool includes expandable members that can be selectively transitioned to an extended position to cause each of the motor components to be radially aligned prior to securely coupling the same in a so-called "stack" to form a motor. Once the motor components are coupled together, the resulting motor includes a rotor shaft extending from end-to-end that preferably includes a sub-micron deviation of less than 10 microns, and more preferably less than or equal to 5 microns, for example.
Patent CA-3161703-A1 (CA)
Inventor: FOSTER DONALD
IPC: A61P9/12
Filed: 2020-11-06
Abstract: The present invention relates to methods of inhibiting the expression of an AGT gene in a subject, as well as methods for treating subjects having an AGT-associated disorder, e.g., hypertension, using RNAi agents, e.g., double stranded RNAi agents, targeting the AGT gene. The invention also relates to methods of decreasing blood pressure levels in a subject using such RNAi agents to inhibit expression of an AGT gene.
Patent CA-3165199-A1 (CA)
Title: Systemes de boucles chimiques presentant au moins deux types de particules
Inventor: FAN LIANG-SHIH
IPC: F23C10/04
Filed: 2020-09-10
Abstract: Des exemples de systèmes de boucles chimiques comprennent au moins un type de particules solides actives et de particules solides inertes qui peuvent être fournies entre divers réacteurs dans des systèmes donnés à titre d'exemple. Certains systèmes de boucles chimiques peuvent comprendre un réacteur à réducteur en communication fluidique avec un réacteur à chambre de combustion. Certains systèmes de boucle chimique peuvent en outre comprendre un réacteur à oxydant en communication fluidique avec le réacteur à chambre de combustion et le réacteur à réducteur. Généralement, les particules solides actives sont capables de circuler entre une réaction de réduction et une réaction d'oxydation. Généralement, les particules solides inertes ne sont pas des réactifs que ce soit dans la réaction de réduction ou la réaction d'oxydation.
Patent CA-3166326-A1 (CA)
Inventor: ROBERTS MARK JULIAN
IPC: C10L3/10
Filed: 2022-06-27
Abstract: Described herein are methods and systems for producing liquefied natural gas (LNG) from a methane-containing synthetic gas (MCSG). An MCSG feed stream may be cooled and partially liquefied using one or more heat exchanger units. A first phase separator and a second phase separator in downstream fluid flow communication with the first phase separator may be used to separate the partially liquefied MCSG stream into a first residue gas stream and first and second feed streams, the first and second feed streams then being fed into a distillation column to produce an LNG stream and a second residue gas stream.
Patent CA-3168580-A1 (CA)
Title: Procede ameliore d'emballage et de conservation a long terme de produits carnes sans chaine frigorifique
Inventor: VAUDAGNA SERGIO
IPC: A23B4/005
Filed: 2020-12-15
Abstract: Procédé amélioré d'emballage et de conservation à long terme de produits carnés sans chaîne frigorifique, ce qui permet d'éviter la perte de liquides lors du rayonnement, afin d'améliorer la conservation et le maintien des propriétés organoleptiques des morceaux de viande.
Patent CA-3168907-A1 (CA)
Title: System for aseptic packaging and method of using the same
Inventor: SANFILIPPO JOHN
IPC: B65B37/02
Filed: 2021-01-27
Abstract: Systems and methods of aseptic processing of product can include a hopper for introduction of the product into the system and one or more components through which the product flows as it is processed through the system, an enclosure surrounding one more of the components, a gassing assembly comprising a plurality of gassing elements for maintaining a substantially constant flow of inert gas over the product as it travels through the components of the system, and filtered gas recirculation system that recirculates filtered air or gas through the enclosure. Such systems can be particularly advantageous for use in the cannabis industry.
Patent CA-3173198-A1 (CA)
Title: Two-part clamping building support hanger
Inventor: CARLSON LOGAN
IPC: E04B1/38
Filed: 2021-04-14
Abstract: A hanger for attaching an elongate beam to a building support includes a first member attachable to a second member. The first member includes a side and a web section with locking teeth. The second member includes a slot with at least one locking tooth. The slot of the second member may be formed in a second web section. The first member and second member are lockable to each other at a plurality of different lateral positions to accommodate elongate beams having a variety of thicknesses.
Patent CA-3173290-A1 (CA)
Title: Compositions and methods
Inventor: ABI AOUN WALID
IPC: A24B3/14
Filed: 2021-09-03
Abstract: The present invention provides an amorphous solid for use in aerosol generation, the amorphous solid comprising: about 1 to about 50 wt% cannabidiolic acid (CBDA); about 10 to about 80 wt% aerosol-former material; gelling agent; and optionally filler, wherein the amount of gelling agent and optional filler taken together is from about 10 to about 60 wt%; wherein the wt% values are calculated on a dry weight basis.
Patent CA-3176208-A1 (CA)
Title: Methods for treating myelin associated diseases and mitochondria associated diseases
Inventor: BETTOUN JOAN DAVID
IPC: A61P37/06
Filed: 2021-04-30
Abstract: The present disclosure provides methods for treating or ameliorating a myelin associated disease or a mitochondria associated disease that comprising administering to a subject in need thereof a frataxin replacement therapeutic compound, e.g, a fusion protein comprising frataxin.
Patent CA-3179427-A1 (CA)
Inventor: BITTNER JOHN D
IPC: F24F1/42
Filed: 2021-05-19
Abstract: An evaporative cooling device for a refrigeration system includes one or more heat exchanger coils, a first moisture panel, a second moisture panel, a first nozzle array, a second nozzle array, a moisture sensor, and a controller. The first moisture panel and the second moisture panel are separated by a distance and disposed external to the one or more heat exchanger coils. The first nozzle array is disposed external to the first moisture panel and the second nozzle array is disposed external to the second moisture panel. The first nozzle array and the second nozzle array are configured to provide an atomized spray of electrostatically charged droplets. The moisture sensor is configured to provide a signal representative of a moisture level. The controller is configured to receive the signal representative of the moisture level and control a supply of water.